baber/WOPTO huggingface dataset:
Patent NZ-507281-A (NZ)
Title: Lineage specific cells and progenitor cells
Inventor: SMITH AUSTIN
IPC: C12N5/073
Filed: 1999-04-14
Abstract: A method for generating a culture that is purified or enriched in respect of cells of a selected lineage is disclosed. A selectable marker, which is differentially expressed in cells of the selected lineage compared with its expression in other cells, is introduced into a multipotential cell and the multipotential cell is cultured to induce differentiation of the multipotential cell into a cell of the selected lineage or into a mixture of cells including cells of the selected lineage, or is cultured to induce preferential survival of cells of the selected lineage. Those cells that express the selectable marker are then selected for.
Patent NZ-507938-A (NZ)
Title: Aspartyl dipeptide ester derivatives and sweeteners
Inventor: AMINO YUSUKE
IPC: A23L17/10
Filed: 1999-03-11
Abstract: Aspartyl dipeptide ester derivatives of formula (1) wherein ; R1, R2, R3, R4 and R5 are H, hydroxyl, alkoxy, alkyl or hydroxyalkyloxy, or; R1 and R2, or R2 and R3 together form a methylenedioxy group wherein R4, R5, and R1 or R3 which does not form the methylenedioxy group as a part thereof, represent any substituents as mentioned above designated for the R1, R3, R4 and R5, respectively; R6 is hydrogen or hydroxyl; R7 is methyl, ethyl, isopropyl, n-propyl or t-butyl; The derivatives in which R1 to R5 are all hydrogen atoms, and the derivatives in which R2 is a methoxy group and R3 is a hydroxyl group are excluded. Also described is a sweetener comprising a derivative of formula (1) as the active ingredient.
Patent NZ-509201-A (NZ)
Title: Microstructured optical fibres
Inventor: BROENG JES
IPC: G02B6/02
Filed: 1999-05-21
Abstract: The present invention relates to a new class of optical waveguides, in which waveguiding along one or more core regions is obtained through the application of the Photonic Bandgap (PBG) effect. The invention further relates to optimised two-dimensional lattice structures capable of providing complete PBGs, which reflects light incident from air or vacuum. Such structures may be used as cladding structures in optical fibres, where light is confined and thereby guided in a hollow core region. In addition, the present invention relates to designs for ultra low-loss PBG waveguiding structures, which are easy to manufacture. Finally, the present invention relates to a new fabrication technique, which allows easy manufacturing of preforms for photonic crystal fibers with large void filling fractions, as well as it allows a high flexibility in the design of the cladding and core structures.
Patent NZ-511695-A (NZ)
Title: Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
Inventor: LOGTENBERG TON
IPC: A61K39/00
Filed: 1999-10-18
Abstract: A process for altering the properties of a cell and/or a  particle comprising a membrane derived from the cell, the process  comprising the step of contacting the  cell  and/or the  particle  with a lipid-modified proteinaceous  molecule comprising at least one protein moiety derived from a  first protein  and at least one lipidation signal derived  from  a bacterial lipoprotein.
Patent NZ-511936-A (NZ)
Title: Stabilization of macrolides
Inventor: NAVARRO FRANCOIS
IPC: A61K/
Filed: 1999-12-06
Abstract: A process for stabilizing rapamycin or a rapamycin derivative having immunosuppressant properties comprising: i) Dissolving the pure rapamycin or rapamycin derivative in an inert solvent. ii) Adding an antioxidant to the resulting solution in an amount of up to 1% based on the rapamycin or rapamycin derivative weight. iii) Isolating the resulting mixture of the rapamycin or rapamycin derivative and the antioxidant. Also described is a mixture in solid form comprising a rapamycin or a rapamycin derivative having immunosuppressant properties, and an antioxidant, the antioxidant being present in an amount of up to 1% based on the rapamycin or rapamycin derivative weight.
Patent NZ-513533-A (NZ)
Title: Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
Inventor: DUKLER AVINOAM
IPC: C12P19/00
Filed: 2000-02-17
Abstract: A combinatorial complex carbohydrate library comprising a plurality of addressable complex carbohydrate structure, each of said addressable complex carbohydrate structures being attached, at a dedicated location, to a solid support having a platform configuration. Also covered is a method of producing said library and uses of the library including for identifying a complex carbohydrate capable of binding an entity, and a method of diagnosing a disorder by self or non-self complex carbohydrate structures and elicitation of antibodies there against.
Patent NZ-513645-A (NZ)
Title: Insulated bulkhead
Inventor: HORNER JOHN F
IPC: E05C21/02
Filed: 2001-08-20
Abstract: A bulkhead (2) includes an upper member and a lower member which are vertically adjustable to vary the height of the bulkhead. The bulkhead has reduced thickness portion (27) along at least one vertical edge. The reduced thickness portion is configured to overlap with a reduced thickness portion of another bulkhead in order to vary the width of the partition.
Patent NZ-520410-A (NZ)
Title: An appliance having a workpiece engageable head
Inventor: MORRISON PAUL JOHN
IPC: A61F2/30
Filed: 2002-07-25
Abstract: A surgical impactor with a surgical implant engagement end and a surgeon's manipulation end is disclosed. A collet is located at the engagement end of the impactor. The collet has an uncollapsed mode in which it defines a segmented male thread, adapted to screw engage a female thread of a surgical implant. A control at the surgeon's manipulation end can be used to collapse or relax the collet to a withdrawal mode to allow its withdrawal from within the surgical implant.
Patent NZ-520599-A (NZ)
Title: Inflatable support
Inventor: KEMP DANIEL
IPC: A61G7/05
Filed: 2001-12-07
Abstract: A support surface 10 includes a series of inflatable cells 30, 40 inflated alternately by a compressor 11. The cells 30, 40 are exhausted via an exhaust port 50 having a restrictor 60 of known diameter. A pressure transducer 70 measures the cell 30, 40 pressure. Some of the cells 30, 40 during their deflating/inflating cycle are exhausted through the exhaust port 50 and the cell pressure decay over a time is monitored. A microprocessor calculates the mathematical function related to the cell pressure decay with time, compares the value with compiled data and adjusts the output of the compressor accordingly. The sequence of exhausting via port 50 is repeated at every inflation/deflation cycle and the pressure decay monitored and compared with the known data and the compressor output adjusted automatically to provide a new operating pressure. Therefore, any changes in the person's position are accommodated by the cell pressure automatically being adjusted to prevent bottoming or high interface pressures. Instead of the cell pressure the flow rate change may be measured. The user may also be able to adjust the support pressure to some extent by remote control. The support is used in the prevention and treatment of pressure sores.
Patent NZ-521453-A (NZ)
Title: Clay-containing mixture or blend capable of forming a moisture resistant gel, and use of that mixture and blend
Inventor: WAMMES JACOBUS CORNELIS
IPC: C09K17/40
Filed: 2001-03-16
Abstract: A clay-containing mixture, which comprises a ground or powdered smectite or a rock containing the smectite.  The mixture further contains a partially water-soluble or water-swellable linear chain acrylaminde type (co) polymer.  The polymer having a molecular weight of at least 500.000, a hydrolysis degree of at most 30% and a particle size of 2µm to 1 mm.  The mixture also contains 3-20% of water.
Patent NZ-521738-A (NZ)
Title: Dental implant-carrier assembly with features to enhance implant stability and transportation and positioning of an implant-carrier
Inventor: ANITUA ALDECOA EDUARDO
IPC: A61C8/00
Filed: 2001-09-14
Abstract: Disclosed is an implant having a cutting thread with a tapered straight edge and a hexagonal end. A carrier system (not shown) for implant transportation and installation consists of a connector, a transport shaft and an implant mount connector. The connector has hexagonal ends and an o-ring seal is provided between the transport shaft and implant mount connector.
Patent NZ-526089-A (NZ)
Title: Heterocyclic ether substituted imidazoquinolines and pharmaceutical compositions for cytokine induction, anti-tumor activty and antiviral activity
Inventor: CHARLES LESLIE JAYNE
IPC: A61P31/12
Filed: 2001-12-06
Abstract: The compounds of formula (I)-(IX) and (XLIV) or pharmaceutically acceptable salts are described wherein: X is -CHR3-, -CHR3-alkyl- or-CHR3-alkenyl-; R1 is -heteroaryl, -heterocyclyl, -R4-heteroaryl or -R4-heterocyclyl, and in formulas (V) and (VI) R1 can also be -(CH2)1-10-CºC-R10; R2 is -hydrogen, -alkyl, -alkenyl, -aryl, -heteroaryl, -heterocyclyl, -alkyl-Y-alkyl, -alkyl-Y-alkenyl, -alkyl-Y-aryl, or -alkyl or alkenyl substituted by one or more substituents selected from the group consisting of -OH, -halogen, -N(R3)2, -CO-N(R3)2, -CO-C1-10alkyl, -CO-O-C1-10alkyl, - N3, -aryl, -heteroaryl, -heterocyclyl, -CO-aryl, and -CO-heteroaryl; R4 is alkyl or alkenyl, which may be interrupted by one or more -O- groups; Each R3 is independently H or C1-10alkyl; Each Y is independently -O-or-S(O)0-2-; n is 0 to 4; and each R present is independently selected from the group consisting of C1-10alkyl, C1-10 alkoxy, hydroxy, halogen and trifluoromethyl; and R10 is heteroaryl and heterocyclyl; R7 is tert-butyl or benzyl; and Z is NH2 or NO2. The compounds can be used in the manufacture of a pharmaceutical composition for inducing cytokine biosynthesis, preferably the cytokine IFN-a, for treating viral disease and for treating neoplastic disease.
Patent NZ-526792-A (NZ)
Title: Film coating composition for controlled release from pharmaceutical formulations
Inventor: HOELZER ARNE
IPC: A61P9/00
Filed: 2002-01-22
Abstract: A film coating composition suitable for use in coating pharmaceutical formulations is disclosed, which comprises: a) an acrylic polymer dispersion, e.g. an ethylacrylate/methylmethacrylate copolymer such as Eudragit NE30D; b) a surfactant; c) sodium stearyl fumarate; and d) a water-containing liquid useful for the achievement of controlled release from pharmaceutical formulations such as tablets, pellets, etc.
Patent NZ-527216-A (NZ)
Title: Regulation of organic nitrate tolerance
Inventor: PARKER JOHN D
IPC: A61K31/34
Filed: 2002-01-07
Abstract: Disclosed herein are pharmaceutical compositions useful in obviating or mitigating tolerance during organic nitrate therapy. These pharmaceutical compositions comprise compounds selected from the group comprising a folate compound, a folate derivative compound, tetrahydrobiopterin and mixtures thereof. These pharmaceutical compositions are suitable for the treatment of coronary artery disease and congestive heart failure.
Patent NZ-531266-A (NZ)
Title: Scalable switching system with intelligent control
Inventor: REED COKE
IPC: H04L12/56
Filed: 2002-07-22
Abstract: A parallel information generation, distribution and processing system (900), this scalable, pipelined control and switching system (900) efficiently and fairly manages a plurality of incoming data streams (132, 134), and applies class and quality of service requirements. The present invention also uses scalable MLML switch fabrics to control a data packet switch (930), including a request-processing switch (104) used to control the data-packet switch (930). Also included is a request processor (106) for each output port, which manages and approves all data flow to that output port, and an answer switch (108) which transmits answer packets from request processors (106) back to requesting input ports.
Patent NZ-532610-A (NZ)
Title: Acyclic linker-containing oligonucleotides and uses thereof
Inventor: DAMHA MASAD J
IPC: A61K48/00
Filed: 2002-10-29
Abstract: Oligonucleotides having an internal acyclic linker residue of formula Ia, and the preparation and uses thereof, are described. Wherein a is an integer greater than or equal to 1; R1 and R2 each independently comprise at least one nucleotide; X is an acyclic linker; wherein said oligonucleotide comprises at least one of (I) at least one modified nucleotide and (ii) a chimera. Such uses include the preparation of acyclic linker-containing antisense oligonucleotides, and their use for the prevention or depletion of function of a target nucleic acid of interest, such as RNA, in a system. Such a prevention or depletion of function includes, for example, the prevention or inhibition of the expression, reverse transcription and/or replication of the target nucleic acid, as well as the cleavage/degradation of the target nucleic acid. Accordingly, an oligonucleotide of the invention is useful for analytical and therapeutic methods and uses in which the function of a target nucleic acid is implicated, as well as a component of commercial packages corresponding to such methods and uses.
Patent NZ-532992-A (NZ)
Title: Electrode binder
Inventor: BEUTLER MAIK
IPC: C10G9/00
Filed: 2002-11-26
Abstract: The present invention provides a process for the preparation of an electrode binder, which process comprises: - (a) thermally cracking a non-hydro-treated thermal tar feedstock having an aromatic content of less than 65 % wt; (b) separating the thermally cracked product of step (a) in a separator, into at least a top fraction and a bottom fraction, and (c) subjecting the bottom fraction from step (b) to vacuum distillation, to yield, as a vacuum distillation residue, an electrode binder, and an anode binder obtainable by said process for use in aluminium production.
Patent NZ-538431-A (NZ)
Title: Method for enhancing the nutritive value of plant extract
Inventor: MICHAUD DOMINIQUE
IPC: C12N9/50
Filed: 2003-07-29
Abstract: Disclosed herein is a method for increasing the nutritive value of plant or portion thereof that comprises neutralizing the activity or action of at least one plant proteolysis degradation on at least one endogenous proteins with an inhibitor released from said plant or plant extract at the time plant cells thereof are disrupted.
Patent NZ-539731-A (NZ)
Title: Improved formulations containing substituted imidazole derivatives
Inventor: BANBURY SUSAN
IPC: A61K47/26
Filed: 2003-11-03
Abstract: Disclosed are formulations containing substituted imidazole derivatives of the general formula (I), or a pharmaceutically acceptable salt, such as an acid addition salt, e.g. the hydrochloride of a compound of general formula (I) in solid fast-dispersing dosage forms suitable for pre-gastric absorption.
Patent NZ-542822-A (NZ)
Title: Method for processing fruits and vegetables on the base of lecithin
Inventor: SARDO ALBERTO
IPC: A23J7/00
Filed: 2004-03-24
Abstract: Provided is a method of reducing impairment of the visual appearance or texture of fruit and vegetables or their leaves directly resulting from a physical and/or chemical treatment of fruit and vegetables, the method comprising the step of applying lecithins and/or derivatives to the fruit or vegetable, wherein: - the physical treatments are carried out by means of heat or cold; - the chemical treatments consist of treatment agents, selected from calcium chloride, tolyfluanid, diphenylamine, orthophenylphenol, imazalil, ethoxyquine, hydroxyl-function terpenes having antioxidant and/or fungicidal functions; and - the lecithins and/or derivatives are applied simultaneously, separately or staggered over time, relative to the physical and/or chemical treatment. Further provided are methods comprising lysolecithins, other treatment agents and various oil bases, and methods of preparing the compositions and the compositions as such.
Patent NZ-552231-A (NZ)
Title: Acoustically insulated wall assembly
Inventor: BOSCAINO JOE
Filed: 2006-12-20
Abstract: A wall assembly comprising a masonry wall comprising a first and second array of a plurality of masonry panels arranged in a staggered array. The plurality of masonry panels have a first linerboard secured to one side of the staggered array and a second linerboard secured to the other side of the staggered array. The panels of the first array do not contact each other or any other panels in the second array.
Patent NZ-552909-A (NZ)
Title: Delamination-resistant multilayer container, preform, article and method with oxygen barrier formulations
Inventor: BOURGEOIS PHILIP D
Filed: 2005-07-21
Abstract: Disclosed is a plastic preform for blow molding, a container and an article that includes a multilayer wall having at least one layer of a matrix resin, at least one layer of a barrier resin, an adhesion-promoting material blended with the barrier resin and/or matrix resin, and an active oxygen barrier composition blended with the barrier resin and/or matrix resin. The adhesion-promoting material promotes bonding between the barrier and matrix resin layers and includes an amine polymer, preferably an imine polymer having a number of available primary, secondary or tertiary amine groups. The matrix resin preferably is an ester-containing resin such as PET. The barrier resin preferably is EVOH. The active oxygen barrier composition includes a metal with an additive compound, and may also include a host polymer.
Patent NZ-560538-A (NZ)
Title: An anchor device of wooden or metal structures to a wall
Inventor: CABRELE FEDERICO
Filed: 2007-08-10
Abstract: An anchor device is disclosed. The anchor device 1 comprises an expansion bolt 2, which in turn comprises a tubular body. The tubular body is provided with a hole which extends along a longitudinal axis of the tubular body itself, accommodating a fastening screw 3. The tubular body also comprises a central shank 4 with a head 5 integrated into it. The head consists of a full solid body through which a pair of longitudinally reciprocally perpendicular through-slots 7 are made which delimit at least four anchor segments 8, which are adapted to spread outwards under the bias of the fastening screw. The central shank comprises a first portion, which is arranged next to the head. This portion presents a plurality of longitudinal through-slots 21, 22 substantially orthogonal to a middle plane of the bolt, and each of these slots develops along the first portion in parallel to the longitudinal axis so as to define with an adjacent through-slot a longitudinal anchoring tab, which is adapted to expand radially outwards under the tightening bias of the fastening screw.
Patent NZ-563802-A (NZ)
Title: Low-energy buildings with inner and outer housing and a warm air section to reduce condensation
Inventor: BECHER KLAUS
IPC: E04B1/70
Filed: 2006-04-26
Abstract: Disclosed is diffusely open construction of low-energy house walls, which without a vapour proof protection and vapour proof brake obstructs the creation of condensation water in and on walls. The construction uses a warm air section (3) between an inner house and an outer house, and comprises: an outer wall of the outer house (1); a house framework (4); a transparent roof (5) or a common roof (6); and a heat distribution means (7). A thermally insulated diffusely open wall and ceiling of the inner house (2) allows vapour to be diffused, with the warm air section warmed up by greenhouse heat. The house framework is made of metal, silicates and wood, and supports both the outer house and the inner house. In use, water vapour or other gases diffuse through the walls are prevented from condensating inside the thermally insulated walls of the inner house.
Patent NZ-565126-A (NZ)
Title: Secretion of antibodies without signal peptides from bacteria using a protein localisation (prl) mutation
Inventor: YARRANTON GEOFFREY
IPC: A61K39/395
Filed: 2006-07-07
Abstract: Disclosed is a method for producing an antibody, comprising the steps of: a) culturing a prokaryotic host cell containing a functional prl mutation and at least one expression vector comprising a polynucleotide molecule encoding a heavy chain polypeptide of the antibody and a polynucleotide molecule encoding a light chain polypeptide of the antibody, under conditions that express the polynucleotide encoding the heavy chain polypeptide and the polynucleotide molecule encoding the light chain polypeptide of the antibody, wherein at least one of the polynucleotides encodes a polypeptide lacking a signal peptide, b) secreting the heavy chain polypeptide and the light chain polypeptide across a cytoplasmic membrane, and c) forming the antibody from the heavy chain polypeptide and the light chain polypeptide.
Patent NZ-567092-A (NZ)
Title: Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
Inventor: GRUNENBERG ALFONS
IPC: A61K31/5377
Filed: 2006-09-22
Abstract: Polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-l,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide represented by formula (I), methods for the production thereof, medicaments containing the same, and the use thereof for fighting diseases are disclosed.
Patent NZ-569697-A (NZ)
Title: Method of treatment, prophylaxis and diagnosis of pathologies of the bone by the modulation of GPC3
Inventor: COUSSENS ANNA KATHLEEN
IPC: A61P35/04
Filed: 2007-01-19
Abstract: Disclosed is the use of an agent which modulates expression of a gene or the activity of a product encoded by a human GPC3 gene or a mammalian homolog thereof, and wherein the agent is selected from the Jist consisting of (i) a nucleic acid molecule encoding GPC3; (ii) an antisense DNA or RNA molecule to a nucleic acid molecule enCoding GPC3; (iii) a hairpin RNA or siRNA molecule to a nucleic acid molecule encoding GPC3; (iv) GPC3 protein; and (v) an antibody specific for GPC3 protein, in the manufacture of a medicament for the treatment of a suture-based cranial disorder or bone injury selected from the list consisting of a fracture, greenstick and bone chip in a subject. Further disclosed is the use of an agent as defined above in the manufacture of a medicament for treating a subject to improve bone growth or inhibit bone growth in said subject.
Patent NZ-575661-A (NZ)
Title: Vehicle barrier system with two bases both of which have raisable barrier arms
Inventor: GELFAND MATTHEW A
IPC: E01F15/00
Filed: 2007-09-19
Abstract: Disclosed is a vehicle barrier system. The vehicle barrier system including bases (24) located on opposite sides of an area through which a vehicle may pass, first and second arms (22a, 22b) hingeably mechanically coupled to a base, first, second and third members (20b, 29b, 21), a raising/lowering mechanism and a cable (23) in mechanical communication with at least one of the first, second, and third members, the cable having connecting points (26) located on opposite sides of the area through which a vehicle may pass, and wherein, in one position, at least portions of the first, second, and third members and the cable may be high enough to encounter a front of a vehicle.
Patent NZ-580053-A (NZ)
Title: Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use
Inventor: FRANCO SELMA
IPC: A61P17/00
Filed: 2008-03-14
Abstract: A process for obtaining dry extracts from the leaves of Cymbopogon nardus. The process comprises: i. Breaking down the leaves of Cymbopogon nardus in a solvent comprising an alcoholic organic solvent containing between 1 and 6 carbon atoms and water to obtain an extract; ii. Concentrating the extract by evaporating the organic solvent at a temperature from 35 to 45 degrees Celsius and at reduced pressure near vacuum; and iii. Lyophilizing the concentrated extract to obtain a dried extract. The alcoholic solvent can be ethanol or dipropylene glycol. The extract can be used in an antifungal or anti-trichomonicid pharmaceutical. The pharmaceutical can be used to treat Mycrosporum canis, M. ferrugineum, M. gypeum, Tricophytum mentagrophytes, T. raubistschecki, Trichosporum tonsurans, Candida albicans, C. glabrata, C. parapsilosis, C. tropicalis and Trichomonas vaginalis.